Folger Nolan Fleming Douglas Capital Management’s Zimmer Biomet ZBH Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Sell	3,926 -10	-0.3%	-$877	0.03%	150
2026 Q1	$356K	Sell	3,936 -15	-0.4%	-$1.38K	0.03%	143
2025 Q4	$355K	Sell	3,951 -400	-9%	-$37.9K	0.04%	134
2025 Q3	$429K	Buy	+4,351	New	+$431K	0.04%	122
2023 Q3	–	Sell	-1,665	Closed	-$242K	–	169
2023 Q2	$242K	Hold	1,665	–	–	0.03%	151
2023 Q1	$215K	Hold	1,665	–	–	0.03%	156
2022 Q4	$212K	Buy	+1,665	New	+$193K	0.03%	159
2022 Q2	–	Sell	-2,360	Closed	-$302K	–	165
2022 Q1	$302K	Sell	2,360 -730	-24%	-$88K	0.03%	138
2021 Q4	$381K	Sell	3,090 -268	-8%	-$35.1K	0.04%	127
2021 Q3	$477K	Hold	3,358	–	–	0.06%	116
2021 Q2	$524K	Hold	3,358	–	–	0.06%	114
2021 Q1	$522K	Hold	3,358	–	–	0.06%	113
2020 Q4	$502K	Hold	3,358	–	–	0.07%	112
2020 Q3	$444K	Hold	3,358	–	–	0.07%	110
2020 Q2	$389K	Hold	3,358	–	–	0.06%	111
2020 Q1	$330K	Sell	3,358 -82	-2%	-$10.7K	0.07%	111
2019 Q4	$500K	Hold	3,440	–	–	0.07%	110
2019 Q3	$458K	Hold	3,440	–	–	0.07%	111
2019 Q2	$393K	Hold	3,440	–	–	0.06%	123
2019 Q1	$427K	Sell	3,440 -103	-3%	-$11.7K	0.06%	114
2018 Q4	$357K	Sell	3,543 -208	-6%	-$23.4K	0.06%	117
2018 Q3	$479K	Sell	3,751 -35	-0.9%	-$4.16K	0.07%	109
2018 Q2	$410K	Buy	3,786 +84	+2%	+$9.14K	0.06%	114
2018 Q1	$392K	Hold	3,702	–	–	0.06%	118
2017 Q4	$434K	Sell	3,702 -82	-2%	-$9.27K	0.06%	114
2017 Q3	$430K	Sell	3,784 -1,299	-26%	-$150K	0.06%	116
2017 Q2	$634K	Sell	5,083 -2,858	-36%	-$339K	0.1%	96
2017 Q1	$942K	Hold	7,941	–	–	0.14%	79
2016 Q4	$1.01M	Hold	7,941	–	–	0.17%	79
2016 Q3	$1.01M	Hold	7,941	–	–	0.17%	79
2016 Q2	$929K	Hold	7,941	–	–	0.16%	82
2016 Q1	$822K	Hold	7,941	–	–	0.15%	86
2015 Q4	$790K	Hold	7,941	–	–	0.14%	89
2015 Q3	$724K	Hold	7,941	–	–	0.15%	91
2015 Q2	$842K	Hold	7,941	–	–	0.16%	86
2015 Q1	$906K	Hold	7,941	–	–	0.16%	80
2014 Q4	$874K	Hold	7,941	–	–	0.15%	83
2014 Q3	$775K	Sell	7,941 -103	-1%	-$10.1K	0.14%	85
2014 Q2	$812K	Hold	8,044	–	–	0.15%	86
2014 Q1	$739K	Sell	8,044 -793	-9%	-$73.1K	0.15%	88
2013 Q4	$799K	Hold	8,837	–	–	0.14%	85
2013 Q3	$705K	Buy	8,837 +849	+11%	+$66.8K	0.14%	86
2013 Q2	$582K	Buy	+7,988	New	+$597K	0.12%	89

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's ZBH Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Zimmer Biomet (ZBH) stake by 0.25% in Q2 2026, selling an estimated $877 and leaving 3,926 shares worth $338K. The position accounts for 0.03% of the portfolio, ranked #150.

Folger Nolan Fleming Douglas Capital Management first reported a position in ZBH in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.01M in Q4 2016. 475 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Folger Nolan Fleming Douglas Capital Management held 3,926 shares of Zimmer Biomet worth $338K as of Q2 2026.
Folger Nolan Fleming Douglas Capital Management sold 10 Zimmer Biomet shares in Q2 2026, an estimated $877.
Zimmer Biomet made up 0.03% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #150 holding.
Folger Nolan Fleming Douglas Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 43 quarters since.
Folger Nolan Fleming Douglas Capital Management's Zimmer Biomet position peaked at $1.01M in Q4 2016.
475 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.